v3.26.1
Stockholders’ Equity (Tables)
3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Schedule of Changes in Preferred Stock Outstanding

The following table summarizes the changes in Preferred Stock outstanding for the quarter ended March 31, 2026:

 

   Shares 
Outstanding at December 31, 2025   3,155 
Issued    
Converted to Common Stock    
Outstanding at March 31, 2026   3,155 
Schedule of Shareholder Equity Warrants Outstanding

A summary of warrants outstanding as of March 31, 2026 and December 31, 2025 were as follows:

 

   Shares 
Outstanding at December 31, 2024   666,667 
Issued   11,262,808 
Exercised   (946,266)
Expired   (466,666)
Outstanding at December 31, 2025   10,516,543 
Issued    
Exercised    
Exchanged    
Expired    
Outstanding at March 31, 2026   10,516,543 
Schedule of Potentially Dilutive Securities Excluded from Computation Of Diluted Net Loss Per Share

The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share because including them would have been anti-dilutive as of March 31, 2026 and 2025:

 

 Schedule of Potentially Dilutive Securities Excluded from Computation Of Diluted Net Loss Per Share

   2026   2025 
   As of March 31, 
   2026   2025 
Stock options   436,468    483,489 
Convertible preferred stock upon conversion   5,383,964    2,815,702 
Warrants   10,516,543    6,298,071 
Total   16,336,975    9,597,262